Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1976 1
1979 1
1988 1
1996 1
1997 1
1999 1
2000 1
2001 1
2002 1
2003 2
2004 4
2005 1
2006 3
2007 4
2008 6
2009 2
2010 8
2011 6
2012 11
2013 5
2014 13
2015 11
2016 11
2017 12
2018 17
2019 14
2020 7
2021 8
2022 4
2023 4
2024 6

Text availability

Article attribute

Article type

Publication date

Search Results

138 results

Results by year

Filters applied: . Clear all
Page 1
Response.
Hill AT, Gold PM, El Solh AA, Metlay JP, Ireland B, Irwin RS; CHEST Expert Cough Panel. Hill AT, et al. Chest. 2019 May;155(5):1082-1083. doi: 10.1016/j.chest.2019.02.014. Chest. 2019. PMID: 31060697 No abstract available.
Treading carefully.
Mermikides A, Richardson S, Firth T, Newcombe P, Norman K. Mermikides A, et al. Among authors: newcombe p. Br J Nurs. 2018 Jul 12;27(13):728. doi: 10.12968/bjon.2018.27.13.728. Br J Nurs. 2018. PMID: 29995508 No abstract available.
A Randomized Phase I Study of the Anti-Interleukin-33 Antibody Tozorakimab in Healthy Adults and Patients With Chronic Obstructive Pulmonary Disease.
Reid F, Singh D, Albayaty M, Moate R, Jimenez E, Sadiq MW, Howe D, Gavala M, Killick H, Williams A, Krishnan S, Godwood A, Shukla A, Hewitt L, Lei A, Kell C, Pandya H, Newcombe P, White N, Scott IC, Cohen ES. Reid F, et al. Among authors: newcombe p. Clin Pharmacol Ther. 2024 Mar;115(3):565-575. doi: 10.1002/cpt.3147. Epub 2024 Jan 24. Clin Pharmacol Ther. 2024. PMID: 38115209 Clinical Trial.
Type I interferon blockade with anifrolumab in patients with systemic lupus erythematosus modulates key immunopathological pathways in a gene expression and proteomic analysis of two phase 3 trials.
Baker T, Sharifian H, Newcombe PJ, Gavin PG, Lazarus MN, Ramaswamy M, White WI, Ferrari N, Muthas D, Tummala R, Morand EF, Furie RA, Vital EM, Chamberlain C, Platt A, Al-Mossawi H, Brohawn PZ, Csomor E. Baker T, et al. Among authors: newcombe pj. Ann Rheum Dis. 2024 Jul 15;83(8):1018-1027. doi: 10.1136/ard-2023-225445. Ann Rheum Dis. 2024. PMID: 38569851 Free article. Clinical Trial.
Homozygous p.Ser267Phe in SLC10A1 is associated with a new type of hypercholanemia and implications for personalized medicine.
Liu R, Chen C, Xia X, Liao Q, Wang Q, Newcombe PJ, Xu S, Chen M, Ding Y, Li X, Liao Z, Li F, Du M, Huang H, Dong R, Deng W, Wang Y, Zeng B, Pan Q, Jiang D, Zeng H, Sham P, Cao Y, Maxwell PH, Gao ZL, Peng L, Wang Y. Liu R, et al. Among authors: newcombe pj. Sci Rep. 2017 Aug 23;7(1):9214. doi: 10.1038/s41598-017-07012-2. Sci Rep. 2017. PMID: 28835676 Free PMC article.
138 results